Bayer 91555 FC Patch-low contraceptive study
Investigator: Philip D. Darney, MD, MS
Sponsor: Bayer HealthCare Pharmaceuticals, Inc
Location(s): United States
The primary objective of this study was to investigate the contraceptive efficacy of the transdermal contraceptive patch.
The secondary objective was to investigate the safety profile. Compliance and subjective assessment of satisfaction with the transdermal contraceptive patch were also evaluated.